Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
BelgiumLong‑Term Safety and Efficacy Study of ENTR‑601‑45 and ENTR‑601‑44 in Participants with Duchenne Muscular Dystrophy
BelgiumDuchenne Muscular Dystrophy in Patients with Gene Mutations Amenable to Exon 44 Skipping Treated with Delpacibart Zotadirsen
BelgiumA study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1
BelgiumA Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease
BelgiumA study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy
BelgiumStudy on Long-Term Safety and Efficacy of VX-670 for Adults with Myotonic Dystrophy Type I
BelgiumStudy of ENTR-601-45 Safety and Effectiveness in Patients with Duchenne Muscular Dystrophy Who Can Skip Exon 45
BelgiumStudy of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment
BelgiumStudy Comparing the Safety and Effectiveness of Mexiletine PR and Mexiletine IR for Adults with Non-Dystrophic Myotonias
BelgiumStudy on the Effects of Mexiletine for Treating Myotonic Dystrophy Types 1 and 2 in Patients
BelgiumLong-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat
Belgiumpowered by
